Publication | Closed Access

Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases

NanoparticlesNanomedicineEngineeringProtein NanoparticlesPolymer-drug ConjugateBudesonide DeliveryNano-drug DeliveryBiomedical EngineeringDrug Delivery SystemPharmacologyInflammatory Bowel DiseasesRedox-sensitive NanoparticlesBioavailability